---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-108864"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2023-10-12T23:59:59+00:00"
generated_at: "2026-06-10T00:41:09.949018+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# AbbVie expands board to 13, appoints Jennifer Davis and Susan Quaggin as directors

## Summary
- Board expanded from 11 to 13 directors; Jennifer Davis (Class II) and Susan Quaggin (Class III) appointed.
- Davis is CEO, Health Care at Procter & Gamble; Quaggin is Irving S. Cutter Professor and Chair of Medicine at Northwestern.
- Davis appointed to Nominations and Governance Committee; Quaggin to Public Policy and Sustainability Committee.
- Board affirmatively determined both are independent under NYSE standards and AbbVie guidelines.

## SEC filing metadata
- accession: 0001104659-23-108864
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2023-10-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/0001104659-23-108864-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-108864
- JSON: https://secwatch.observer/filing/0001104659-23-108864.json
- Plain text: https://secwatch.observer/filing/0001104659-23-108864.txt

## Key facts
- Executive change
  Jennifer Davis was appointed as Class II director at AbbVie Inc..
  - Action: appointed
  - Role: Class II director
  source text: appointed Jennifer Davis as a Class II director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/0001104659-23-108864-index.htm
- Executive change
  Susan Quaggin was appointed as Class III director at AbbVie Inc..
  - Action: appointed
  - Role: Class III director
  source text: and Susan Quaggin as a Class III director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/0001104659-23-108864-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.